Professor of Pediatrics, Microbial Pathogenesis, and Public Health
Yale School of Medicine
MC has provided a day of consulting services to Janssen Pharmaceuticals, manufacturers of mebendazole for the treatment of soil transmitted helminth infections. MC does not currently receive consulting fees or research support.
Dr Michael Cappello would like to gratefully acknowledge Dr Samantha H. Johnston and Dr Claire Panosian, previous contributors to this topic. SHJ owns a share in a company (Merck & Co., Inc.) that produces ivermectin, an alternative therapy for ascariasis. CP declares that she has no competing interests.
Stanford Health Promotion Network
Stanford School of Medicine
YM declares that he has no competing interests.
Department of Medical Parasitology and Mycology
School of Public Health
Tehran University of Medical Sciences
MBR declares that he has no competing interests.